glp-1 weight regain after stopping receptor agonists | Gustavo Monnerat posted on the topic Those discontinuing GLP-1 medications rapidly

The US market is also witnessing a pivotal affordability shift

At the full 12mg maintenance dose, the majority experience some degree of nausea during the first few weeks, though this typically fades substantially by weeks 8-12 at that dose level

GLP-1 agonists must be administered subcutaneously, not intramuscularly

It is currently undergoing clinical trials

You can find more information on Contrave and pregnancy here, and more information on phentermine and pregnancy here

A new prior authorization is generally not needed for: Regular monthly refills An increase in dose A decrease in dose Your provider must still send a new prescription when your dose changes